Company Financials

BioCryst Pharmaceuticals, Inc. Financials

United States dollar

business BioCryst Pharmaceuticals, Inc. Company Profile

Main Stock Listing

NASDAQ: BCRX

Market Capitalization $1.58 Billion as of Jan. 1, 2026

Market Cap History

Valuations Metrics as of Jan. 3, 2026

Trailing PE -17.44
Forward PE 24.00
Price to Sales TTM $2.64
Price to Book MRQ $-4.06
Enterprise to Revenue 3.42
Enterprise to EBITDA 25.48

Financial Reports as of Sep. 30, 2025

Financials

Fiscal Year Ends 2024-12-31
Most Recent Quarter 2025-09-30
Profit Margin -1.46%
Operating Margin 18.57%
Return on Assets TTM 10.31%
Return on Equity TTM 18.68%

Income Statement

Revenue TTM $599,816,000
Revenue per Share TTM $2.87
Quarterly Revenue Growth 36.10%
Gross Profit TTM $410,454,016
EBITDA $13,449,000
Net Income to Common TTM $-8,779,000
Diluted EPS TTM $-0.05
Quarterly Earnings Growth YoY 36.14%

Balance Sheet

Total Cash MRQ $212,872,992
Total Cash per Share MRQ $1.01
Total Debt MRQ $
Total Debt to Equity MRQ -1.76
Current Ratio MRQ 1.87
Book Value per Share MRQ $-1.84

Cash Flow

Operating Cash Flow TTM $50,196,000
Levered Free Cash Flow TTM $63,339,752

BCRX Stock Info as of Jan. 3, 2026

Stock Statistics

Shares Outstanding 210,521,833
Float Shares 180,692,406
Avg 10 Volume 2,994,650
Avg 30 Volume None
Shares Short 36,006,145
Short Ratio 9.14
Short % of Shares 17.15%
% Held by Insiders 1.43%
% Held by Institutions 101.47%

Stock Price Summary

Beta 0.91
Fifty Two Week Low $6.00
Fifty Two Week High $11.31
Fifty Two Week Change -4.40%
Day 50 MA $7.29
Day 200 MA $8.26

Dividends and Splits

Forward Annual Dividend Rate $
Forward Annual Dividend Yield %
Trailing Annual Dividend Rate $0.00
Trailing Annual Dividend Yield 0.00%
Payout Ratio 0.00%
Dividend Date
Ex Dividend Date 2014-06-11
Last Split Factor
Last Split Date